doi: 10.4155/fmc-2020-0191 175 MikhailovskiiOXueYSkrynnikovNR
Non-GLP-1 wellness products such as NAD+, sermorelin, and lipotropics are also available
They also display eat-me signals, such as phosphatidylserine (PS), on their surface, which are identified by specific receptors on phagocytes, such as the TAM family receptors MerTK and Axl, as well as Tim-4 and BAI1 (Xiao et al., 2024)
Your body isnt just ignoring your efforts, its actively working against them, staying stuck in fat-storage mode
5,12,13 These efforts have yielded six GLP-1 RAsstarting with the development of exendin-4 (Figure 1B)-based exenatide (Figure 1C), followed by liraglutide (Figure 1D), albiglutide, dulaglutide (Figure 1E), lixisenatide, and semaglutide (Figure 1F)that have been approved by the United States Food and Drug Administration (US FDA) to treat type 2 diabetes